These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 15226351)
1. Association between TGFBR1*6A and cancer: is there any evidence? Lai R J Clin Oncol; 2004 Jul; 22(13):2754; author reply 2754-5. PubMed ID: 15226351 [No Abstract] [Full Text] [Related]
2. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies. Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057 [TBL] [Abstract][Full Text] [Related]
3. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk. Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241 [TBL] [Abstract][Full Text] [Related]
4. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk. Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881 [TBL] [Abstract][Full Text] [Related]
5. Int7G24A variant of the TGFBR1 gene and cancer risk: a meta-analysis of three case-control studies. Zhang HT Lung Cancer; 2005 Sep; 49(3):419-20. PubMed ID: 15955593 [No Abstract] [Full Text] [Related]
6. TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. Pasche B; Kaklamani V; Hou N; Young T; Rademaker A; Peterlongo P; Ellis N; Offit K; Caldes T; Reiss M; Zheng T J Clin Oncol; 2004 Feb; 22(4):756-8. PubMed ID: 14966109 [No Abstract] [Full Text] [Related]
7. Role of TGF-beta in cancer and the potential for therapy and prevention. Kaklamani VG; Pasche B Expert Rev Anticancer Ther; 2004 Aug; 4(4):649-61. PubMed ID: 15270668 [TBL] [Abstract][Full Text] [Related]
8. Is TGFBR1*6A a susceptibility allele for nonsyndromic familial colorectal neoplasia? Daley D; Morgan W; Lewis S; Willis J; Elston RC; Markowitz SD; Wiesner GL Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):892-4. PubMed ID: 17507611 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk. Spillman MA; Schildkraut JM; Halabi S; Moorman P; Calingaert B; Bentley RC; Marks JR; Murphy S; Berchuck A Gynecol Oncol; 2005 May; 97(2):543-9. PubMed ID: 15863158 [TBL] [Abstract][Full Text] [Related]
11. No association between TGFBR1*6A and lung cancer. You W; Liu Z; Zhao J; Zheng M; Zheng SY; Liu X; Zhang HT J Thorac Oncol; 2007 Jul; 2(7):657-9. PubMed ID: 17607123 [TBL] [Abstract][Full Text] [Related]
12. Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies. Wang YQ; Qi XW; Wang F; Jiang J; Guo QN PLoS One; 2012; 7(8):e42899. PubMed ID: 22905183 [TBL] [Abstract][Full Text] [Related]
13. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls. Liao RY; Mao C; Qiu LX; Ding H; Chen Q; Pan HF Mol Biol Rep; 2010 Oct; 37(7):3227-32. PubMed ID: 19882361 [TBL] [Abstract][Full Text] [Related]
14. No major association between TGFBR1*6A and prostate cancer. Kaklamani V; Baddi L; Rosman D; Liu J; Ellis N; Oddoux C; Ostrer H; Chen Y; Ahsan H; Offit K; Pasche B BMC Genet; 2004 Sep; 5():28. PubMed ID: 15385056 [TBL] [Abstract][Full Text] [Related]
15. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy. McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955 [TBL] [Abstract][Full Text] [Related]
16. Bioinformatic and functional analysis of TGFBR1 polymorphisms. Schirmer MA; Hoffmann AO; Campean R; Janke JH; Zidek LM; Hoffmann M; Kruse M; Sehrt D; Tzvetkov MV; Rave-Fränk M; Brockmöller J Pharmacogenet Genomics; 2009 Apr; 19(4):249-59. PubMed ID: 19214138 [TBL] [Abstract][Full Text] [Related]
17. Effect of formal statistical significance on the credibility of observational associations. Ioannidis JP Am J Epidemiol; 2008 Aug; 168(4):374-83; discussion 384-90. PubMed ID: 18611956 [TBL] [Abstract][Full Text] [Related]
18. Building a knowledge base on genetic variation and cancer risk through field synopses. Yesupriya A; Gwinn M; Khoury MJ J Natl Cancer Inst; 2009 Jan; 101(1):4-5. PubMed ID: 19116390 [No Abstract] [Full Text] [Related]
19. Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes. Siezen CL; Bont L; Hodemaekers HM; Ermers MJ; Doornbos G; Van't Slot R; Wijmenga C; Houwelingen HC; Kimpen JL; Kimman TG; Hoebee B; Janssen R Pediatr Infect Dis J; 2009 Apr; 28(4):333-5. PubMed ID: 19258923 [TBL] [Abstract][Full Text] [Related]
20. TGFbeta1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies. Wei BB; Xi B; Wang R; Bai JM; Chang JK; Zhang YY; Yoneda R; Su JT; Hua LX Cancer Genet Cytogenet; 2010 Jan; 196(1):68-75. PubMed ID: 19963138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]